Home > PB Ratio > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of EMCURE PHARMACEUTICALS is 6.80.

Share Price ₹1,054.9Apr 02,2025
Market Cap ₹19,990.4 Cr
Book Value₹2,937.8 CrMar2024 - Consolidated Results
Price/Book 6.80xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of EMCURE PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of EMCURE PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹19,990.4 Cr] as on Apr 02,2025

(/) Book Value [ ₹2,937.8 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 6.80x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for EMCURE PHARMACEUTICALS , the investors are currently willing to pay '6.80 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of EMCURE PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of EMCURE PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of EMCURE PHARMACEUTICALS


PB Ratio Performance Analysis for EMCURE PHARMACEUTICALS

- EMCURE PHARMACEUTICALS 's latest p/b ratio is 6.80x.

- EMCURE PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.

- EMCURE PHARMACEUTICALS 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, EMCURE PHARMACEUTICALS 's p/b ratio peaked in Mar2024 at 0x.

- EMCURE PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2024 of 0x.


How does EMCURE PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
EMCURE PHARMACEUTICALS 2,937.796.8019,990.4
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.46411,306.0
DIVIS LABORATORIES LTD13,571.0011.08150,343.0
CIPLA LTD26,619.904.41117,323.0
TORRENT PHARMACEUTICALS LTD6,856.1515.84108,619.0
DR REDDYS LABORATORIES LTD28,123.503.4195,941.5
MANKIND PHARMA LTD9,339.8410.7099,891.5
ZYDUS LIFESCIENCES LTD19,829.504.5289,680.6
LUPIN LTD14,175.806.4791,742.2
AUROBINDO PHARMA LTD29,842.802.2567,294.6
ABBOTT INDIA LTD3,658.7317.1862,839.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs EMCURE PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.25x
Max industry PB 17.18x
Median industry PB 6.47x
Average industry PB 8.10x



You may also like the below Video Courses